Link Pharma Chem Ltd Stock Price Today (NSE: LINKPH)

Link Pharma Chem Ltd

26.81+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Link Pharma Chem Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Link Pharma Chem Ltd share price today is 26.81, up +0.00% on NSE/BSE as of 17 June 2026. Link Pharma Chem Ltd (LINKPH) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 15.33 (Cr). The 52-week high for LINKPH share price is 42.80 and the 52-week low is 21.00. The company has a Return on Equity (ROE) of -7.81% and a debt-to-equity ratio of 0.62.

Link Pharma Chem Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
30.59
Low
26.81
Volume
786.95
Change
-3.71%

Link Pharma Chem Ltd share price chart: -3.71% return over the past month. 52-week high ₹42.80, 52-week low ₹21.00.

Link Pharma Chem Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
27.0028.0127.0027.0065.00 (Cr)
29.3529.3527.0027.002.52K (Cr)
28.0028.0027.0028.00372.00 (Cr)
27.4429.4027.4428.065.98K (Cr)
28.0028.0028.0028.00100.00 (Cr)
28.7029.4928.0028.00575.00 (Cr)
29.8829.8828.4029.13123.00 (Cr)
30.4730.4729.8829.88132.00 (Cr)
29.0329.0329.0329.031.00 (Cr)
30.0030.0027.5527.65359.00 (Cr)

Link Pharma Chem Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
29.3529.3527.0027.00-8.01%
29.6630.4727.0028.00-5.60%
24.8931.9023.5029.76+19.57%
23.5032.0021.0022.66-3.57%
28.4032.0026.4427.30-3.87%
34.4534.4526.4029.50-14.37%
33.5034.5429.6530.80-8.06%
35.1735.8030.1533.59-4.49%
41.9041.9031.0035.00-16.47%
33.5541.0032.2536.66+9.27%
32.1839.9432.0033.15+3.01%
39.5042.8032.6033.29-15.72%

AI Research Briefing

Powered by Gemini · 2026-04-17

Micro-cap commodity chemical company with weak fundamentals; positive momentum is likely a mirage.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEConsolidation. 1M: -1.31%, 3M: 1.59%, 6M: -3.79%Expensive. P/E is non-existent due to losses, while the industry P/E is 20.98x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. Markets Mojo upgraded Link Pharma Chem from 'Strong Sell' to 'Sell' based on improved technical indicators and valuation metrics. On April 9, 2026, 29% from the previous close.

CORE STORY (THE REAL GAME)

This is a micro-cap commodity chemical play, sensitive to cyclical demand and raw material price fluctuations. The market seems to be reacting to short-term valuation improvements rather than fundamental changes in the business.

Why Now
  • Valuation upgrade by Markets Mojo
  • Mildly bullish technical indicators
  • Improved quarterly sales and profit
Potential Catalysts
  • Significant order wins
  • Sharp increase in commodity chemical prices
  • Debt restructuring
Key Risks
  • Micro/SME cap: Illiquidity risk
  • Negative ROE and ROCE
  • High debt/equity ratio (0.62) and negative interest coverage (-0.5x)
Institutional Activity

No significant FII/DII activity. Promoter holding stable at 51.49%.

Macro Context

Indian chemical production projected to increase by 10.9% in 2026, driven by robust domestic demand and government support.

Cash Flow Quality

No. Free Cash Flow 5Y is ₹0.09 Cr.

3–6 Month Outlook

Short-term: Potential for continued gains if technical indicators remain positive. Long-term: Unsustainable without fundamental improvements in profitability and debt management.

Primary Thesis Risk

Inability to service debt will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

-7.81%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-3.00%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

4.87%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Link Pharma Chem Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

20.98x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

51.49%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.02%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

106.45%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

31.04%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-0.03%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.62x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

-0.50x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

0.09 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Link Pharma Chem Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of LINKPH across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (106.45%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (31.04%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Balanced Promoter Holding (51.49%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (-7.81%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-3.00%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (4.87%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Limited Growth History (-0.03% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (-0.50x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Limited Institutional Interest (FII+DII: 0.02%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Link Pharma Chem Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare Link Pharma Chem Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
26/100
27
₹15.33
-7.81%
Poor
-3.00%
Poor
0.6
Good
-0.03%
Poor
0.00%
SRF Ltd...
SRF503806
49.8/100
2737
₹86606.52
53.5
Average
10.37%
Average
12.27%
Average
0.3
Excellent
4.40%
Average
15.30%
Excellent
0.25%
14.9/100
775
₹20261.08
62.2
Average
1.20%
Poor
3.96%
Poor
0.3
Excellent
-47.92%
Poor
7.53%
Good
1.38%
57/100
1448
₹17120.52
17.4
Average
15.56%
Good
15.67%
Good
0.7
Good
94.55%
Excellent
17.00%
Excellent
0.74%
52.8/100
516
₹7381.56
11.6
Average
7.08%
Poor
9.57%
Poor
0.0
Excellent
3.30%
Average
8.86%
Good
3.58%
Ghcl Ltd...
GHCL500171
40.4/100
463
₹5520.31
9.7
Average
18.57%
Good
24.19%
Excellent
0.0
Excellent
8.63%
Good
-0.75%
Poor
2.09%
19.7/100
18
₹5397.73
9306.4
Average
2.12%
Poor
2.57%
Poor
0.0
Excellent
173.71%
Excellent
0.00%
24.4/100
222
₹4503.74
-5.93%
Poor
1.83%
Poor
1.0
Good
28.15%
Excellent
0.00%
68.7/100
1972
₹4106.65
43.7
Average
32.05%
Excellent
41.76%
Excellent
0.1
Excellent
38.64%
Excellent
27.58%
Excellent
0.22%
28/100
687
₹3866.17
25774.5
Average
-1.13%
Poor
-0.34%
Poor
0.1
Excellent
8.37%
Good
3.01%
59.7/100
72
₹3614.14
23.9
Average
17.58%
Good
23.34%
Excellent
0.0
Excellent
17.17%
Excellent
12.90%
Good
0.63%

Link Pharma Chem Ltd Quarterly Performance

Latest quarterly metrics for LINKPH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

31.04%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

106.45%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-0.03%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Link Pharma Chem Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for LINKPH — calculated from daily price history

44RSI 14
Neutral — RSI 44

Momentum is balanced — neither overbought nor oversold.

SMA 50
27
▼ Price below SMA 50 — Short-term bearish
SMA 200
32
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
1K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Link Pharma Chem Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Link Pharma Chem Ltd (LINKPH) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Link Pharma Chem Ltd

About LINKPH (Link Pharma Chem Ltd)

Link Pharma Chem Ltd is a prominent manufacturer of high-quality commodity chemicals, playing a critical role in supplying essential building blocks for diverse industries. Focused... on providing consistent and reliable raw materials, the company leverages advanced production techniques to deliver core chemical components to manufacturers around the globe. Link Pharma Chem is committed to upholding stringent quality control measures, ensuring that its commodity chemicals meet rigorous industry standards and client specifications. Through strategic sourcing and efficient supply chain management, Link Pharma Chem offers competitive pricing and timely delivery, establishing itself as a trusted partner for businesses seeking dependable chemical inputs. The company specializes in the production of key intermediates used in a broad range of applications. These include the foundational components necessary for creating polymers, solvents, and other critical industrial products. Link Pharma Chem’s commitment to innovation drives continuous improvement in its manufacturing processes, optimizing yields and minimizing environmental impact. Furthermore, the company maintains a dedicated team of experts who provide technical support and guidance to customers, ensuring seamless integration of its products into their respective manufacturing processes. This customer-centric approach solidifies Link Pharma Chem's position as a solution provider in the commodity chemical market. Link Pharma Chem Ltd prioritizes sustainability and environmental responsibility in its operations. It invests in technologies that minimize waste generation and reduce its carbon footprint. By adhering to strict environmental regulations and implementing eco-friendly practices, the company strives to operate as a responsible steward of the environment. This commitment to sustainability not only benefits the planet but also enhances the company's reputation and strengthens its relationships with environmentally conscious customers. As the demand for sustainable chemical solutions grows, Link Pharma Chem is well-positioned to meet the evolving needs of the industry.

Company Details

Symbol:LINKPH
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Mr. Satish Ganpatro Thakur
Whole-Time Chairman
Mr. Rishikesh S. Thakur
MD & Director
Mr. Sanjib Dutta
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date

LINKPH Share Price: Frequently Asked Questions

What is the current share price of Link Pharma Chem Ltd?

Link Pharma Chem Ltd (LINKPH) trades at ₹26.81 on NSE and BSE. Market cap ₹15.33 (Cr). Educational data only.

What is the P/E ratio of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has a P/E of N/Ax vs industry average 20.98x.

What is the Bull Run score for Link Pharma Chem Ltd?

Link Pharma Chem Ltd has a Bull Run score of 26/100 based on 25+ financial parameters.

Does Link Pharma Chem Ltd pay dividends?

Link Pharma Chem Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has ROE of -7.81%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has debt-to-equity of 0.62.

Is Link Pharma Chem Ltd a good investment?

Bull Run gives Link Pharma Chem Ltd a score of 26/100. This is not investment advice — consult a SEBI-registered advisor.